XML 18 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Note 11 - Stock Options
6 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Note 11 - Stock Options

NOTE 11 – STOCK OPTIONS

 

As of June 30, 2019, options to purchase 5,000,000 shares of common stock under the Company’s stock option plan were authorized and reserved for future grant. A summary of activity in the stock option plan for the six months ended June 30, 2019 is as follows:

 

  2019
      Weighted-
      Average
  Number   Exercise
  of Shares   Price
       
Outstanding as of beginning of the period 1,580,000   $ 0.25
Granted 3,586,000   0.78
Exercised -   -
Forfeited or expired -   -
Outstanding as of end of the period 5,166,000   0.62
       
Exercisable as of end of the period 5,166,000   0.62

 

As of June 30, 2019, options exercisable and options outstanding had a weighted average remaining contractual term of 2.6 years and had an aggregate intrinsic value of $313,314.

 

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for the grants made in the six months ended June 30, 2019:

 

  2019
Expected life (in years) 2.6
Risk free rate 2.5%
Volatility 393.1%
Dividend yield -

 

Expected option life and volatility are based on historical data of the Company.   The risk-free interest rate is calculated based on the average US Treasury bill rate that corresponds with the option life.  Historically, the Company has not declared dividends and there are no foreseeable plans to do so.

 

As of June 30, 2019, there was $2,701,689 of unrecognized share-based compensation cost related to grants under the stock option plans that will be recognized over a weighted-average period of 2.6 years.

 

Share-based compensation expense included in selling, general and administrative expense in the statements of income for each of the six-month periods ended June 30, 2019 and 2018 was $404,004 and $0, respectively. Share-based compensation expense included in selling, general and administrative expense in the statements of income for each of the three-month periods ended June 30, 2019 and 2018 was $290,757 and $0, respectively.